AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2011
Nov 22, 2011
31542_dirs_2011-11-22_0c67328e-1e5f-4a16-85ab-3986250e337f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2011-11-14
Reporting Person: Rieger Richard (VP Commercial Operations)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to purchase common stock | $1.01 | 2016-11-14 | Common Stock (33333) | Direct | |
| Options to purchase common stock | $1.01 | 2016-11-14 | Common Stock (33333) | Direct | |
| Options to purchase common stock | $1.01 | 2016-11-14 | Common Stock (33334) | Direct |
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6